Login to Your Account



'Two' good to be true? Patient group rejoices in Amgen Repatha win

By Randy Osborne
Staff Writer

Thursday, August 27, 2015

Approval came right on time for Repatha, Amgen Inc.'s PCSK9 inhibitor, with a label that includes HoFH.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription